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Measles virus hemagglutinin has been isolated by immunoadsorption. The total composition of the protein 
and its N-terminal amino acid sequence give data matching the structure indirectly deduced from cDNA. 
However, direct analysis of the hemagglutinin also shows that the mature protein is proteolytically pro- 
cessed and has a partly heterogeneous N-terminus. The initiator Met is removed, and non-stoichiometrically 
also the second residue. 
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1. INTRODUCTION 
The envelope of measles virus consists of a lipid 
bilayer of cellular origin into which the viral 
glycoproteins, the hemagglutinin and the fusion 
protein, are inserted as integral membrane pro- 
teins. The measles virus hemagglutinin protein 
chain has an estimated M, of 79000-80000 [l-3], 
and is responsible for virus adsorption to cells by 
interaction with a cell receptor [4]. The hemag- 
glutinin molecule is a disulfide-bonded structure, 
probably a dimer of a single type of polypeptide 
chain [5,6], forming a spike with truncated conical 
shape [7] on the surface of virions and infected 
cells. 
Most viral membrane-associated glycoproteins 
analyzed have membrane-inserted segments in the 
C-terminal regions, and signal peptides as well as 
initiator methionine residues that are cleaved off in 
post-translational events [&lo]. Unlike this com- 
mon orientation of membrane glycoproteins, in- 
fluenza A virus neuraminidase has been suggested, 
from analysis of a corresponding cDNA, to be at- 
tached to the viral membrane by its N-terminal 
region [I 11, for which a non-processed N-terminal 
end, absence of a signal peptide segment, and 
presence of the initiator methionine have been 
shown by direct protein analysis [12]. A similar 
structural organization was concluded for the in- 
fluenza B neuraminidase [ 131. The N-terminus of 
hemagglutinin-neuraminidase protein of Newcas- 
tle disease virus appears to be blocked, and is 
assumed to be inserted into the membrane [lo]. 
cDNA-deduced amino acid sequences of the 
hemagglutinin-neuraminidase proteins of Sendai 
virus [ 141 and Simian virus 5 [ 151 reveal one major 
hydrophobic region near the N-terminus assumed 
to represent the trans-membraneous part. The 
similarly deduced 617-residue amino acid sequence 
of the measles virus hemagglutinin also has a ma- 
jor hydrophobic region at positions 35-58, in the 
N-terminal segment of the molecule [16]. 
However, the measles virus hemagglutinin protein 
has not been directly analyzed and the aim of the 
present study was to demonstrate whether the 
measles virus hemagglutinin has an unprocessed N- 
terminal end or if it undergoes post-translational 
cleavage. 
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2. MATERIALS AND METHODS Table 1 
2.1. Isolation of the measles virus hemagglutinin 
Amino acid composition of measles virus hemagglutinin 
glycoprotein 
The protein was isolated by affinity 
chromatography as a major step [17]. Confluent 
HeLa cells were infected with plaque purified LEC 
(KI) strain of measles virus. At full infection, cells 
were pelleted and lysed by addition of 0.01 M Tris- 
HCl (pH 7.8), 0.15 M NaCI, 1% aprotinin, 2 mM 
phenylmethylsulfonyl fluoride, 5 mM EDTA and 
3% Triton X-100. From the clarified solution, the 
hemagglutinin was extracted by anti-hemag- 
glutinin monoclonal antibodies immobilized on 
protein A-Sepharose. The immunocomplex was 
excessively washed with lysis buffer and the 
hemagglutinin was separated from immuno- 
globulins by preparative polyacrylamide gel elec- 
trophoresis in the presence of mercaptoethanol. 
Polypeptide bands, identified as the 79 kDa 
hemagglutinin monomer, were excised from the 
gels, and the protein extracted in 1% SDS by 
rocking at 37°C for 72 h. The hemagglutinin was 
then precipitated with trichloroacetic acid, washed 
with acetone and subjected to further analysis. 
protein 
Residue Determined Predicted [ 16) 
(mol%) (mol%) 
Asx 10.5 10.8 
Thr 5.9 6.1 
Ser 8.3 8.2 
GlX 9.1 8.2 
Pro 7.6 5.7 
GlY 8.5 6.7 
Ala 5.0 5.0 
Val 7.3 8.1 
Met 2.1 2.7 
Be 4.7 6.1 
Leu 10.5 11.4 
Tyr 4.3 4.4 
Phe 3.6 3.1 
LYS 5.6 5.1 
His 2.1 2.5 
Arg 5.0 5.2 
CYs and Trp Presently not analyzed and not included in 
the values above 
3.2. N-terminal sequence analysis 
2.2. Structural analysis 
Amino acid compositions were determined by 
acid hydrolysis and subsequent amino acid analysis 
on a Beckman 121M instrument. Gas-phase se- 
quencer degradations were carried out in an Ap- 
plied Biosystems 790A instrument. Phenylthio- 
hydantoin derivatives were identified by high- 
performance liquid chromatography (Hewlett 
Packard 109OB). 
Results of gas-phase sequencer analysis of the 
protein are given in table 2. One major sequence 
was followed for 15 cycles. It corresponds to 
residue 2-16 of the cDNA-derived indirectly 
deduced amino acid sequence for the hemag- 
glutinin [16], establishing that the major form of 
the mature protein has lost the initiator 
methionine. 
3. RESULTS 
3.1. Total composition 
The total composition of the hemagglutinin as 
determined by acid hydrolysis is shown in table 1. 
The composition of the preparation analyzed is in 
agreement with that indirectly determined from 
analysis of the corresponding cDNA, as also 
shown in table 1. Consequently, correct 
assignments in the indirectly derived structure are 
supported. 
In addition, a second sequence was clearly visi- 
ble, yielding the same structure, but one cycle 
earlier in each case (table 2). It corresponds to 
residues 3- 17 in the cDNA-deduced amino acid se- 
quence [ 161, showing that N-terminal proteolytic 
processing has progressed one step further in a 
substantial part of the mature polypeptide 
molecules. The amounts of the ‘longer’ and 
‘shorter’ polypeptide chains were roughly 75 and 
25%, respectively (table 2), yielding a ‘ragged’ N- 
terminal end. Together, the recovery of these two 
structures account for about half the molar yield in 
relation to the amount of protein initially applied 
to the glass fiber in the gas-phase sequencer. Con- 
sidering that yields of initial coupling frequently 
are only somewhat over 50%, the present 
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Table 2 
Results of amino acid sequence analysis 
Cycle Major yield Minor yield 
(pm00 (%I of total) 
1 Ser 200 Pro 24 
2 Pro 302 Gin 19 
3 Gin 324 Arg 26 
4 Arg 64 Asp 25 
5 Asp 162 Arg 24 
6 Arg 82 Ile 22 
7 Ile 374 Asn 24 
8 Asn 155 Ala 17 
9 Ala 253 Phe 20 
10 Phe 384 Tyr 25 
11 Tyr 259 Lys 25 
12 Lys 222 Asp 30 
13 Asp 118 Asn 23 
14 Asn 111 Pro 22 
1.5 Pro 198 His 25 
Average yield 
of total 71% 23% 
As shown, two residues were detected in each cycle but 
could be distinguished because of differences in yield, 
the major peptide representing about 80~~ of the total 
recovery, and the minor about 20%. Results were 
obtained by degradation of about 1 nmol hemagglutinin 
protein and phenylthiohydantoin identification by 
reverse-phase high-performance liquid chromatography 
Further structures in minor yield were also visi- 
ble especially in the initial cycles of the degrada- 
tions, and are compatible with a low amount of ad- 
ditional poiypeptide chains. However, they could 
not be identified as further processing variants of 
the hemaggIutinin molecule, and might therefore 
represent contaminants or completely different 
cleavage products. Degradations of one further 
preparation also showed the presence of additional 
contaminants, while still another preparation of 
the hemagglutinin fully confirmed the present 
results, establishing the reproducibility. 
4. DISCUSSION 
4.1. Nature of the measles vinrs hemaggltd inin 
recoveries show that the major structure deter- 
mined is also the major polypeptide chain present 
in the hemagglutinin preparation. 
The structures of the hemagglutinin polypeptide 
from measles virus and hemagglutinin- 
neuraminidase proteins from Simian virus 5 and 
Sendai virhs have been predicted from analyses of 
corresponding cDNAs 114-161. However, the 
measles virus protein itself has never been directly 
analyzed previously. The total composition (table 
1) and the N-terminal amino acid sequence (table 
2) now obtained therefore form a direct support 
for the correctness of the hemagglutinin structure 
indirectly deduced. Furthermore, the protein data 
establish that the mature hemagglutjnin is N- 
terminally processed by removal of the initiator 
methionine (formally shifting the numbering 
system of the hemagglutinin amino acid sequence 
12 3 b 5 6 ‘I 8 9 10 11 12 13 14 15 16 
Xorslos virus H Ideterminod~ 
I 
fro Gin Atg Asp Arg Ile Asn Ala Pho Tyr Lys Asp Asn Pro Nit 1232) 
Ser Pro 61n Are Asp Arg Ile Asn Ala Phe tyr Lys Asp Asn Pro ~772) 
8terstss virus H fprodrcteddl #et SW Pro Gin Arg Asp Arg Ilt Asn Al& Phi8 Tyr Lys Asp Asn Pro Hi: 
!&cairn virus 5 HW lpredictod) Het Val Ala 61~ Asp Ala Pro Val Arg Ala Thr Cys Arg Val Lou Phe Arg 
Smdai virus WI (pr*dictedJ Mot Asp Gly Asp Asp Gly Lys Arg Alp Sor Tyr Trp Ser Thr Ser Phe Ser 
Fig.1. Comparison of the N-terminal structures of three paramyxovirus hemagglutinin (H) and hemagglutinin- 
neuraminid~e (HN) proteins. The directly determined data for the measles virus hemagglutinin are from table 2, the 
predicted data from the report of the corresponding cloned cDNA [16]. Simil~ly, the predicted data for Simian virus 
5 are from [15] and for Sendai virus hemagglutinin-neuraminidase from [14]. The numbering system is given for the 
major form of the mature measles virus protein now analyzed. 
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[16] by one residue). They also reveal that the 
polypeptide is sensitive to further processing and 
that a minor part of the mature protein consists of 
polypeptides tarting at position 2 (corresponding 
to position 3 of the cDNA-deduced amino acid se- 
quence [ 16]), giving a heterogeneous N-terminal 
starting position in the mature preparation. Conse- 
quently, measles virus hemagglutinin belongs to 
the proteins with a ragged N-terminal end. Similar 
heterogeneity in N-terminal starting position is 
also observed in mitochondrial proteins [18], 
where the ragged N-terminal ends probably reflect 
native processing differences. Ragged N-terminal 
ends are also common in several enzymes and hor- 
mones, where the origin of the heterogeneity is still 
not fully established (e.g. [19-211). 
The N-terminal structure is of interest in relation 
to acetylation of polypeptide chains. Thus, struc- 
tural polypeptides are frequently N-terminally 
acetylated [22], the acetylation being especially 
common with N-terminal serine, which is the 
residue now detected after the initial removal of 
the initiator methionine (table 2), as well as with 
methionine itself [22]. Consequently, N-terminal 
acetylation with resulting blocked polypeptide 
chains could have been expected from the structure 
of the cDNA-deduced amino acid sequence [161, 
preventing direct N-terminal analysis [23], as in 
many other indirectly deduced structures. 
Although a small proportion of N-acetyl-Met 
blocked or N-acetyl-Ser blocked polypeptide 
chains in the hemagglutinin preparation cannot be 
excluded, the present yields upon direct sequence 
analysis (table 2) show that the polypeptide chains 
with free N-terminal serine are the major consti- 
tuents (table 2). In fact, empirical rules for the 
methionine removal of nascent proteins in general 
[24] also predict removal of the initiator 
methionine when the subsequent residue is serine. 
Finally, in relation to N-terminal segments of 
the hemagglutinin and the fusion proteins, it is of 
interest to note a difference in pattern for the 
variability of special regions in the two paramyx- 
ovirus surface proteins. Thus, comparison of the 
Fr subunit of the fusion protein of the measles 
virus with other paramyxovirus fusion proteins 
shows extreme conservation in the N-terminal end 
[ 171, while the membrane-inserted N-terminal 
region of the measles virus hemagglutinin now 
analyzed exhibits extensive variability in com- 
156 
parison to corresponding regions of other 
paramyxoviruses (fig. 1). In biological terms, these 
findings indicate that for the membrane fusion 
process a strictly conserved region is a prerequisite, 
while the events in which the hemagglutinin on the 
cytoplasmic side of the membrane participates (i.e. 
presumably in matrix-nucleocapsid protein 
recognition in the budding process [S]) apparently 
permit large variations. 
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